Solventum Corp reported $1.95B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Align Technology USD 1.02B 40M Sep/2026
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Cencora USD 88.4B 3.6B Sep/2026
Dexcom USD 1.34B 30M Sep/2026
Insulet USD 842M 40.3M Sep/2026
Solventum Corp USD 1.95B 250M Sep/2026
West Pharmaceutical Services USD 874.5M 2.2M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026